GlassScriptPhysician profile
Kaitlin E Hilliard
NPI 1093172686
$4,035.39
in general payments reported to CMS, 2019-2025
26 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2022: $2,226 · 2023: $309 · 2024: $538 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,068.71 | 2022-2023 | Mako |
| Depuy Synthes Sales INC. | $350.93 | 2021-2025 | Monovisc, Orthovisc |
| E.R. Squibb & Sons, L.L.C. | $221.02 | 2025 | Reblozyl |
| Tempus Ai, INC | $142.65 | 2025 | Xt Cdx |
| Ferring Pharmaceuticals INC. | $140.11 | 2021-2023 | Euflexxa |
| Regeneron Healthcare Solutions, INC. | $127.44 | 2024 | Libtayo |
| Pacira Therapeutics, INC. | $118.61 | 2021 | |
| Endo Pharmaceuticals INC. | $118.45 | 2021-2023 | Xiaflex |
| Caris Mpi, INC. | $108.18 | 2025 | Mi Cancer Seek |
| Rigel Pharmaceuticals, INC. | $90.99 | 2024 | Tavalisse, Rezlidhia |
| Irhythm Technologies, INC. | $88.28 | 2023 | Zio Xt Patch |
| Bioventus LLC | $60.36 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Endo USA, INC. | $60.21 | 2024 | Xiaflex |
| Radius Health, INC. | $54.67 | 2024 | Tymlos |
| Sonex Health, INC. | $37.98 | 2023 | Sx-One Microknife |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $36.12 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Pfizer INC. | $29.08 | 2023-2024 | |
| Abbvie INC. | $28.70 | 2022 | |
| Globus Medical, INC. | $24.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.09 | 2024 | Exparel, Zilretta, Iovera |
| Daiichi Sankyo INC. | $22.33 | 2025 | Datroway |
| Boston Scientific Corporation | $20.57 | 2024 | |
| Array Biopharma INC | $20.32 | 2025 | Lorbrena, Mektovi, Braftovi |
| Kowa Pharmaceuticals America, INC. | $14.88 | 2023 | Seglentis |
| Smith+Nephew, INC. | $13.40 | 2021 | |
| Trevena, INC. | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Hilliard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.